Outcomes | Total (N = 1585) | < 1 course (n = 673): (1) | 1 course (n = 783): (2) | > 1 course (n = 129): (3) | P value | Adjusted odds ratio (95% CI) for < 1 course | Adjusted odds ratio (95% CI) for > 1 course |
---|---|---|---|---|---|---|---|
Neonatal | |||||||
APGAR score < 7 (1 min) | 269 (17.0%) | 96 (14.3%) | 140 (17.9%) | 33 (25.6%) | 0.005ab | 0.777 (0.584–1.034) | 1.499 (0.962–2.336) |
APGAR score < 7 (5 min) | 78 (4.9%) | 33 (4.9%) | 35 (4.5%) | 10 (7.8%) | 0.279 | 1.139 (0.697–1.859) | 1.899 (0.907–3.976) |
Post-natal adaptation | 66 (4.2%) | 23 (3.4%) | 39 (5.0%) | 4 (3.1%) | 0.271 | 0.703 (0.414–1.193) | 0.627 (0.219–1.799) |
Bronchopulmonary dysplasia | 45 (2.8%) | 18 (2.7%) | 22 (2.8%) | 5 (3.9%) | 0.752 | 0.929 (0.487–1.769) | 1.376 (0.504–3.761) |
Pneumonia | 54 (3.4%) | 15 (2.2%) | 29 (3.7%) | 10 (7.8%) | 0.005ab | 0.609 (0.322–1.148) | 2.516 (1.179–5.371) |
Pneumothorax | 30 (1.9%) | 9 (1.3%) | 19 (2.4%) | 2 (1.6%) | 0.301 | 0.552 (0.247–1.237) | 0.757 (0.173–3.324) |
Intraventricular haemorrhage | 61 (3.8%) | 23 (3.4%) | 29 (3.7%) | 9 (7.0%) | 0.15 | 0.908 (0.515–1.600) | 1.838 (0.840–4.023) |
Necrotising enterocolitis | 45 (2.8%) | 12 (1.8%) | 28 (3.6%) | 5 (3.9%) | 0.041c | 0.515 (0.258–0.982) | 1.002 (0.372–2.701) |
Neonatal death | 34 (2.1%) | 14 (2.1%) | 16 (2.0%) | 4 (3.1%) | 0.736 | 0.997 (0.479–2.076) | 1.569 (0.504–4.884) |
Sepsis | 145 (9.1%) | 48 (7.1%) | 76 (9.7%) | 21 (16.3%) | 0.003ab | 0.729 (0.499–1.065) | 1.785 (1.050–3.034) |
Hypothermia | 41 (2.6%) | 17 (2.5%) | 18 (2.3%) | 6 (4.7%) | 0.294 | 1.144 (0.582–2.247) | 2.033 (0.778–5.311) |
Phototherapy | 917 (57.9%) | 370 (55.0%) | 450 (57.5%) | 97 (75.2%) | < 0.001ab | 0.928 (0.752–1.145) | 2.180 (1.420–3.349) |
Transient tachypnoea of the newborn | 344 (21.7%) | 141 (21.0%) | 163 (20.8%) | 40 (31.0%) | 0.028ab | 1.001 (0.775–1.292) | 1.719 (1.134–2.606) |
Ventilator support | 194 (12.2%) | 89 (13.2%) | 82 (10.5%) | 23 (17.8%) | 0.036a | 1.281 (0.928–1.768) | 1.861 (1.115–3.107) |
Continuous positive airway pressure | 320 (20.2%) | 117 (17.4%) | 166 (21.2%) | 37 (28.7%) | 0.008b | 0.786 (0.603–1.025) | 1.448 (0.948–2.210) |
Positive pressure ventilation | 201 (12.7%) | 88 (13.1%) | 86 (11.0%) | 27 (20.9%) | 0.007a | 1.257 (0.912–1.731) | 2.140 (1.313–3.486) |
Intermediate care unit admission | 1107 (69.8%) | 491 (73.0%) | 549 (70.1%) | 67 (51.9%) | < 0.001ab | 1.137 (0.903–1.432) | 0.474 (0.323–0.695) |
Neonatal intensive care unit admission | 344 (21.7%) | 133 (19.8%) | 164 (20.9%) | 47 (36.4%) | < 0.001ab | 0.946 (0.730–1.225) | 2.160 (1.444–3.232) |
Respiratory distress syndrome | 72 (4.5%) | 34 (5.1%) | 29 (3.7%) | 9 (7.0%) | 0.179 | 1.372 (0.824–2.283) | 1.776 (0.812–3.886) |
Persistent tachypnoea of the newborn | 1 (0.1%) | 1 (0.1%) | 0 (0.0%) | 0 (0.0%) | 0.508 | – | – |
Length of hospital stay (days) | 7 (1–179) | 6 (1–179) | 7 (1–179) | 14 (1–179) | < 0.001abc | – | – |
Mean neonatal weight (grams) | 2245.5 ± 568.5 | 2327.9 ± 573.6 | 2219.1 ± 556.7 | 1975.6 ± 515.3 | < 0.001abc | – | – |
Maternal | – | – | |||||
Gestational age at delivery (weeks of gestation) | 34.5 ± 2.1 | 34.8 ± 2.0 | 34.4 ± 2.1 | 33.4 ± 2.0 | < 0.001abc | – | – |
Underlying disease | |||||||
Diabetes mellitus (DM) | 28 (1.8%) | 11 (1.6%) | 14 (1.8%) | 3 (2.3%) | 0.842 | 0.913 (0.412–2.204) | 1.308 (0.371–4.616) |
Hypertension | 102 (6.4%) | 37 (5.5%) | 45 (5.7%) | 20 (15.5%) | < 0.001ab | 0.954 (0.610–1.493) | 3.009 (1.712–5.288) |
Others | 153 (9.7%) | 55 (8.2%) | 78 (10.0%) | 20 (15.5%) | 0.034b | 0.804 (0.560–1.155) | 1.658 (0.975–2.821) |
Length of hospital stay (days) | 6 (2–143) | 5 (2–31) | 7 (2–56) | 12 (2–143) | < 0.001abc | – | – |
Puerperal infection | 11 (0.7%) | 5 (0.7%) | 5 (0.6%) | 1 (0.8%) | 0.965 | 1.165 (0.336–4.040) | 1.216 (0.141–10.490) |
Referral to other centres | 21 (1.3%) | 5 (0.7%) | 13 (1.7%) | 3 (2.3%) | 0.182 | 0.443 (0.157–1.250) | 1.410 (0.396–5.019) |